Flutic/salmet 232-14mcg 60 Puffs

Manufacturer TEVA PHARMACEUTICALS USA Active Ingredient Fluticasone and Salmeterol Inhalation Powder(floo TIK a sone & sal ME te role) Pronunciation floo TIK a sone & sal ME te role
It is used to treat asthma.Some brands are used to treat COPD (chronic obstructive pulmonary disease).It may be given to you for other reasons. Talk with the doctor.Do not use this drug to treat intense flare-ups of shortness of breath. Use a rescue inhaler. If you have questions, talk with the doctor.
đŸˇī¸
Drug Class
Antiasthmatic; Bronchodilator, Adrenergic; Corticosteroid, Inhalant
đŸ§Ŧ
Pharmacologic Class
Inhaled Corticosteroid (ICS) / Long-acting Beta2-Adrenergic Agonist (LABA) Combination
🤰
Pregnancy Category
Category C
✅
FDA Approved
Aug 2000
âš–ī¸
DEA Schedule
Not Controlled

Overview

â„šī¸

What is this medicine?

This medication is an inhaler that combines two medicines: a corticosteroid (fluticasone) and a long-acting bronchodilator (salmeterol). The corticosteroid helps reduce inflammation in your lungs, and the bronchodilator helps open up your airways, making it easier to breathe. It's used regularly to prevent asthma attacks or improve breathing in COPD, but it's NOT for sudden breathing problems.
📋

How to Use This Medicine

Proper Use of This Medication

To use this medication correctly, follow your doctor's instructions and read all the information provided. This medication is for inhalation only. Continue using it as directed by your doctor or healthcare provider, even if you feel well. Take your dose at the same time every day.

After each use, rinse your mouth with water, but do not swallow the water. Instead, spit it out. If you are using multiple inhaled medications, consult your doctor about which one to use first.

Preparing and Taking Your Dose

Only prepare a dose when you are ready to take it. If you prepare a dose and then close the inhaler without taking it, the medication will be wasted and the inhaler may be damaged. When taking your dose, do not breathe out into the inhaler. Close the inhaler after use.

Important Safety Precautions

Do not take an extra dose, even if you did not taste or feel the powder. Do not disassemble the device or wash it, and do not use it with a spacer. Also, avoid breathing out into the device.

Cleaning and Maintenance

To clean the mouthpiece, gently wipe it with a dry tissue or cloth. Do not wash the mouthpiece or submerge it in water.

Tracking Your Doses

This inhaler has a built-in dose counter to help you keep track of the number of doses remaining. Once the counter reaches "0," or after 1 month from opening the foil pouch, or when the expiration date is reached (whichever comes first), discard the inhaler.

Storage and Disposal

Store the medication at room temperature in a dry place, away from the bathroom. Keep it in the foil pouch until you are ready to use it.

What to Do If You Miss a Dose

If you miss a dose, skip it and return to your regular dosing schedule. Do not take two doses at the same time or take extra doses.
💡

Lifestyle & Tips

  • Use regularly as prescribed, even if you feel well.
  • Do NOT use for sudden, acute breathing problems; use your rescue inhaler (e.g., albuterol) for those.
  • Rinse your mouth with water and spit it out after each dose to prevent oral thrush (yeast infection in the mouth).
  • Do not exceed the prescribed dose.
  • Keep track of the number of doses used and discard the inhaler after the specified number of actuations or expiration date.
  • Avoid triggers that worsen your asthma or COPD (e.g., smoke, allergens, pollutants).

Dosing & Administration

đŸ‘¨â€âš•ī¸

Adult Dosing

Standard Dose: 1 inhalation (232 mcg fluticasone / 14 mcg salmeterol) twice daily, approximately 12 hours apart
Dose Range: 232 - 232 mg

Condition-Specific Dosing:

asthma: 1 inhalation (232/14 mcg) twice daily
copd: 1 inhalation (232/14 mcg) twice daily
đŸ‘ļ

Pediatric Dosing

Neonatal: Not established
Infant: Not established
Child: Not established for this strength (lower strengths available for younger children, e.g., 100/50 mcg for 12 years and older for asthma)
Adolescent: For asthma, 12 years and older: 1 inhalation (232/14 mcg) twice daily
âš•ī¸

Dose Adjustments

Renal Impairment:

Mild: No dosage adjustment necessary
Moderate: No dosage adjustment necessary
Severe: No dosage adjustment necessary
Dialysis: No specific recommendations; systemic exposure is low

Hepatic Impairment:

Mild: No dosage adjustment necessary
Moderate: Use with caution; monitor for systemic corticosteroid effects
Severe: Use with caution; monitor for systemic corticosteroid effects due to potential for increased systemic exposure of fluticasone propionate
Confidence: Medium

Pharmacology

đŸ”Ŧ

Mechanism of Action

Fluticasone propionate is a synthetic trifluorinated corticosteroid with potent anti-inflammatory activity. It reduces inflammation in the airways, decreasing bronchial hyperreactivity and mucus production. Salmeterol xinafoate is a long-acting selective beta2-adrenergic agonist. It acts locally in the lung to relax bronchial smooth muscle, resulting in bronchodilation, by stimulating adenyl cyclase, which converts ATP to cyclic-3',5'-adenosine monophosphate (cAMP). Increased cAMP levels lead to relaxation of bronchial smooth muscle.
📊

Pharmacokinetics

Absorption:

Bioavailability: Fluticasone: Low systemic bioavailability (oral <1%, inhaled ~30%); Salmeterol: Low systemic absorption
Tmax: Fluticasone: 0.5-1 hour; Salmeterol: 5-10 minutes (for bronchodilation)
FoodEffect: Not applicable for inhaled powder

Distribution:

Vd: Fluticasone: 318 L; Salmeterol: Not extensively studied, but widely distributed
ProteinBinding: Fluticasone: 91%; Salmeterol: 96%
CnssPenetration: Limited

Elimination:

HalfLife: Fluticasone: Approximately 8 hours; Salmeterol: Approximately 5.5 hours
Clearance: Fluticasone: 1150 mL/min; Salmeterol: Not extensively studied, but rapid
ExcretionRoute: Fluticasone: Primarily feces (as metabolites); Salmeterol: Primarily feces (60%) and urine (25%) as metabolites
Unchanged: Fluticasone: <5% in urine; Salmeterol: <1% in urine
âąī¸

Pharmacodynamics

OnsetOfAction: Salmeterol: 10-20 minutes
PeakEffect: Salmeterol: 1-2 hours
DurationOfAction: Salmeterol: 12 hours
Confidence: Medium

Safety & Warnings

âš ī¸

BLACK BOX WARNING

Long-acting beta2-adrenergic agonists (LABAs), such as salmeterol, increase the risk of asthma-related death. Data from a large, placebo-controlled US study in asthma patients showed an increase in asthma-related deaths in patients receiving salmeterol. This finding with salmeterol is considered a class effect of LABAs. The safety and effectiveness of Fluticasone/Salmeterol in patients with asthma have not been established in patients <4 years of age. Fluticasone/Salmeterol is not indicated for the primary treatment of status asthmaticus or other acute episodes of asthma or COPD where intensive measures are required.
âš ī¸

Side Effects

Urgent Side Effects: Seek Medical Help Right Away

Although rare, some people may experience severe and potentially life-threatening side effects while taking this medication. If you notice any of the following symptoms, contact your doctor or seek medical attention immediately:

Signs of an allergic reaction: rash, hives, itching, red, swollen, blistered, or peeling skin (with or without fever), wheezing, tightness in the chest or throat, trouble breathing, swallowing, or talking, unusual hoarseness, or swelling of the mouth, face, lips, tongue, or throat
Signs of infection: fever, chills, severe sore throat, ear or sinus pain, cough, increased or changed sputum production, painful urination, mouth sores, or a wound that won't heal
Signs of high blood sugar: confusion, drowsiness, excessive thirst or hunger, frequent urination, flushing, rapid breathing, or fruity-smelling breath
Signs of low potassium levels: muscle pain or weakness, muscle cramps, or an irregular heartbeat
Signs of a weak adrenal gland: severe nausea or vomiting, severe dizziness or fainting, muscle weakness, extreme fatigue, mood changes, decreased appetite, or weight loss
Signs of high or low blood pressure: severe headache or dizziness, fainting, or changes in vision
Chest pain or pressure
Rapid or abnormal heartbeat
Shakiness
Feeling nervous or excitable
Changes in behavior
Vision changes, eye pain, or severe eye irritation
Abnormal burning, numbness, or tingling sensations
Choking
Changes in voice
Seizures
Bone pain
Sleep disturbances
Feeling extremely tired or weak
Vaginal itching or discharge
Weight gain
Mouth irritation or mouth sores
Redness or white patches in the mouth or throat

Important: This medication can cause severe breathing problems, which may be life-threatening. If you experience difficulty breathing, worsening breathing, wheezing, or coughing after taking this medication, use a rescue inhaler and seek medical help immediately.

Other Possible Side Effects

Like all medications, this drug can cause side effects. Many people may not experience any side effects or only minor ones. If you notice any of the following side effects or any other symptoms that bother you or don't go away, contact your doctor or seek medical attention:

Headache
Upset stomach or vomiting
Throat irritation
* Signs of a common cold

Reporting Side Effects

This list is not exhaustive, and you may experience other side effects. If you have questions or concerns about side effects, contact your doctor. You can also report side effects to the FDA at 1-800-332-1088 or online at https://www.fda.gov/medwatch.
🚨

Seek Immediate Medical Attention If You Experience:

  • Worsening asthma or COPD symptoms (e.g., increased shortness of breath, wheezing, cough)
  • Increased need for your rescue inhaler
  • Chest pain or fast/pounding heartbeat
  • Severe headache or dizziness
  • Tremor or nervousness
  • White patches in your mouth or throat (oral thrush)
  • Blurred vision or eye pain (rare, long-term)
  • Signs of infection (e.g., fever, chills, increased mucus, change in mucus color)
  • Signs of allergic reaction (e.g., rash, hives, swelling of face/lips/tongue, difficulty breathing)
📋

Before Using This Medicine

Before Taking This Medication: Important Information to Share with Your Doctor

It is essential to inform your doctor about the following:

Any allergies you have, including allergies to this medication, its components, or other substances. Be sure to describe the allergic reaction you experienced.
If you are currently taking a similar medication. If you are unsure, consult your doctor or pharmacist for clarification.
Any prescription or over-the-counter medications, natural products, or vitamins you are taking that may interact with this medication. Certain medications used to treat HIV, infections, depression, and other conditions should not be taken with this drug. Your doctor or pharmacist can advise you on potential interactions.
If you have a milk allergy.

Please note that this is not an exhaustive list of all potential interactions or health problems that may affect the use of this medication. To ensure your safety, it is crucial to:

Inform your doctor and pharmacist about all medications (prescription or over-the-counter), natural products, and vitamins you are taking, as well as any health problems you have.
Verify that it is safe to take this medication with all your other medications and health conditions.
* Never start, stop, or change the dose of any medication without first consulting your doctor.
âš ī¸

Precautions & Cautions

Important Warnings and Cautions

When taking this medication, it is essential to inform all your healthcare providers, including doctors, nurses, pharmacists, and dentists, that you are using this drug.

Effectiveness and Monitoring

It may take approximately 1 week to experience the full effects of this medication. If you have diabetes (high blood sugar), consult your doctor, as this medication may increase your blood sugar levels. Immediately contact your doctor if your breathing problems worsen, your rescue inhaler becomes less effective, or you need to use it more frequently.

Dosage and Administration

Do not exceed the recommended dose or use this medication more often than prescribed. Overdosing on this type of medication has been fatal. Consult your doctor if you have any concerns.

Transitioning from Oral Steroids

When switching from an oral steroid to another form of steroid, you may be at risk for severe and potentially life-threatening side effects. Be aware of symptoms such as weakness, fatigue, dizziness, nausea, vomiting, confusion, or low blood sugar. If you experience any of these symptoms, contact your doctor immediately.

In situations where you have a severe injury, undergo surgery, or develop an infection, you may require additional doses of oral steroids to help your body cope with stress. Carry a warning card indicating that you may need extra steroids in these situations.

Long-term Use and Potential Risks

Prolonged use of this medication may increase your risk of developing cataracts or glaucoma. Consult your doctor to discuss this potential risk. It is also recommended that you undergo regular eye exams as advised by your doctor.

Additionally, long-term use may lead to weak bones (osteoporosis). Discuss your risk factors with your doctor and undergo bone density tests as recommended.

Infection Risk and Prevention

You may be more susceptible to infections while taking this medication. To minimize this risk, practice good hygiene by washing your hands frequently and avoiding close contact with people who have infections, colds, or flu.

If you have not had chickenpox or measles before, avoid exposure to these illnesses, as they can be severe or even fatal in people taking steroid medications like this one. If you have been exposed to chickenpox or measles, consult your doctor immediately.

Special Considerations

If you are 65 or older, use this medication with caution, as you may be more prone to side effects.

In children and teenagers, this medication may affect growth in some cases. Regular growth checks may be necessary. Consult your doctor to discuss this potential risk.

If you are pregnant, plan to become pregnant, or are breastfeeding, consult your doctor to weigh the benefits and risks of using this medication.

COPD Considerations

If you have chronic obstructive pulmonary disease (COPD), you are at a higher risk of developing pneumonia. This medication may further increase this risk. Discuss this potential risk with your doctor.
🆘

Overdose Information

Overdose Symptoms:

  • Excessive beta-adrenergic stimulation (e.g., tachycardia, palpitations, tremor, headache, nausea, hypokalemia, hyperglycemia)
  • Signs of hypercorticism (e.g., Cushingoid features, adrenal suppression) with chronic excessive use

What to Do:

Seek immediate medical attention. Treatment is supportive. Call 911 or Poison Control (1-800-222-1222).

Drug Interactions

đŸšĢ

Contraindicated Interactions

  • Concomitant use of other long-acting beta2-adrenergic agonists (LABAs)
🔴

Major Interactions

  • Strong CYP3A4 inhibitors (e.g., ritonavir, ketoconazole, itraconazole, clarithromycin, cobicistat-containing products): May significantly increase systemic exposure to fluticasone and salmeterol, leading to increased risk of systemic corticosteroid effects and cardiovascular effects of salmeterol.
  • Beta-blockers (non-cardioselective): May block the bronchodilatory effect of salmeterol and produce severe bronchospasm in patients with asthma or COPD. Cardioselective beta-blockers should be used with caution.
🟡

Moderate Interactions

  • Diuretics (thiazide or loop): May potentiate hypokalemia and/or ECG changes associated with beta-agonists.
  • Tricyclic antidepressants (TCAs) and Monoamine Oxidase Inhibitors (MAOIs): May potentiate the cardiovascular effects of salmeterol; use with extreme caution or avoid within 2 weeks of discontinuing MAOIs.
  • Other sympathomimetics: May potentiate adverse cardiovascular effects.
đŸŸĸ

Minor Interactions

  • Not many specific minor interactions commonly cited for this combination.

Monitoring

đŸ”Ŧ

Baseline Monitoring

Pulmonary Function Tests (FEV1)

Rationale: To establish baseline lung function and assess disease severity.

Timing: Prior to initiation of therapy

Asthma/COPD Control Assessment

Rationale: To establish baseline symptom control and quality of life.

Timing: Prior to initiation of therapy

Oral Cavity Examination

Rationale: To check for signs of oral candidiasis (thrush).

Timing: Prior to initiation of therapy

📊

Routine Monitoring

Pulmonary Function Tests (FEV1)

Frequency: Periodically (e.g., every 3-12 months for stable patients, more frequently for unstable)

Target: Improvement from baseline, maintenance of optimal lung function

Action Threshold: Significant decline from baseline or lack of improvement

Asthma/COPD Symptoms and Rescue Inhaler Use

Frequency: At each clinical visit (e.g., every 1-6 months)

Target: Reduced frequency and severity of symptoms, minimal rescue inhaler use

Action Threshold: Increased symptoms, increased rescue inhaler use, nocturnal symptoms, exacerbations

Oral Cavity Examination

Frequency: At each clinical visit

Target: Absence of oral candidiasis

Action Threshold: Presence of white patches or soreness in mouth/throat

Growth (Pediatric Patients)

Frequency: Regularly (e.g., every 3-6 months)

Target: Normal growth velocity for age

Action Threshold: Growth retardation

Bone Mineral Density (Long-term, high-dose ICS use)

Frequency: Periodically, especially in patients with risk factors for osteoporosis

Target: Stable bone density

Action Threshold: Significant bone loss

Ocular Examination (Long-term, high-dose ICS use)

Frequency: Annually or as clinically indicated for cataracts/glaucoma

Target: Normal intraocular pressure, absence of cataracts

Action Threshold: Increased intraocular pressure, development of cataracts

đŸ‘ī¸

Symptom Monitoring

  • Worsening shortness of breath or wheezing
  • Increased need for rescue inhaler (e.g., albuterol)
  • Chest tightness or pain
  • Palpitations or rapid heart rate
  • Tremor or nervousness
  • Oral thrush (white patches in mouth/throat)
  • Hoarseness or dysphonia
  • Blurred vision or eye pain (rare, long-term)
  • Signs of systemic corticosteroid effects (e.g., easy bruising, moon face, weight gain, fatigue, weakness)
  • Signs of paradoxical bronchospasm (immediate worsening of breathing after inhalation)

Special Patient Groups

🤰

Pregnancy

Use during pregnancy only if the potential benefit justifies the potential risk to the fetus. Fluticasone/salmeterol is Pregnancy Category C. There are no adequate and well-controlled studies in pregnant women.

Trimester-Specific Risks:

First Trimester: Potential for teratogenicity, though systemic exposure is low. Weigh benefits vs. risks.
Second Trimester: Generally considered safer than first trimester, but still weigh benefits vs. risks.
Third Trimester: Potential for beta-agonist effects on labor (inhibition) and neonatal effects (e.g., hypoglycemia, tachycardia) if systemic exposure is high, though unlikely with inhaled route.
🤱

Lactation

Caution should be exercised when Fluticasone/Salmeterol is administered to a nursing mother. Both fluticasone and salmeterol are excreted in human milk, but systemic exposure in the infant is expected to be low due to low maternal systemic absorption and poor oral bioavailability.

Infant Risk: Low risk of adverse effects to the infant, but monitor for signs of systemic corticosteroid effects or beta-agonist effects (e.g., irritability, poor feeding).
đŸ‘ļ

Pediatric Use

Not indicated for children under 4 years of age. For children 4-11 years, lower strengths are typically used. Monitor growth velocity closely, as inhaled corticosteroids can cause a reduction in growth rate. Monitor for signs of adrenal suppression.

👴

Geriatric Use

No overall differences in safety or effectiveness have been observed between elderly and younger patients. However, elderly patients may be more susceptible to the cardiovascular effects of beta-agonists (e.g., tremor, palpitations, increased blood pressure) and should be monitored.

Clinical Information

💎

Clinical Pearls

  • This medication is a controller medication, not a rescue inhaler. Patients should always have a short-acting beta-agonist (SABA) available for acute symptoms.
  • Proper inhalation technique is crucial for efficacy. Patients should be instructed and periodically re-evaluated on their technique.
  • Rinsing the mouth and spitting after each dose is essential to minimize the risk of oral candidiasis (thrush) and systemic corticosteroid absorption.
  • Patients should be advised not to stop therapy abruptly, especially if on high doses, due to the risk of adrenal insufficiency.
  • Monitor for signs of pneumonia in COPD patients, as ICS use may increase this risk.
  • Regular follow-up is important to assess asthma/COPD control, adjust therapy if needed, and monitor for adverse effects.
🔄

Alternative Therapies

  • Inhaled Corticosteroid (ICS) monotherapy (e.g., fluticasone propionate, budesonide)
  • Long-acting Beta2-Adrenergic Agonist (LABA) monotherapy (not for asthma without ICS)
  • Long-acting Muscarinic Antagonist (LAMA) (e.g., tiotropium, umeclidinium) for COPD
  • Oral corticosteroids (for severe exacerbations or refractory disease)
  • Leukotriene Receptor Antagonists (LTRAs) (e.g., montelukast)
  • Biologic therapies (e.g., omalizumab, mepolizumab, dupilumab) for severe asthma
💰

Cost & Coverage

Average Cost: Varies widely, typically $300-$600+ per 60-puff inhaler
Generic Available: Yes
Insurance Coverage: Tier 2 or Tier 3 (Preferred or Non-Preferred Brand/Generic)
📚

General Drug Facts

If your symptoms or health issues persist or worsen, it is essential to contact your doctor for further guidance. To ensure your safety, never share your medication with others or take someone else's medication. Some medications may come with an additional patient information leaflet, so it's a good idea to check with your pharmacist. If you have any questions or concerns about this medication, don't hesitate to discuss them with your doctor, nurse, pharmacist, or other healthcare provider. In the event of a suspected overdose, immediately call your local poison control center or seek emergency medical attention. When seeking help, be prepared to provide detailed information about the overdose, including the medication taken, the amount, and the time it occurred.